Jorge Correia Selected Research

Jorge Correia Research Topics

Disease

14	Neoplasms (Cancer) 01/2024 - 08/2013
12	Breast Neoplasms (Breast Cancer) 01/2023 - 08/2013
12	Carcinoma (Carcinomatosis) 01/2022 - 08/2013
3	Neoplasm Metastasis (Metastasis) 11/2021 - 01/2019
2	Chronic Kidney Failure (Chronic Renal Failure) 10/2023 - 01/2023
1	Thrombosis (Thrombus) 10/2023
1	Weight Loss (Weight Reduction) 07/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Vomiting 12/2022
1	Lethargy 12/2022
1	Colonic Neoplasms (Colon Cancer) 08/2022
1	COVID-19 02/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Obesity 01/2021
1	Overweight 01/2021
1	Infections 01/2019
1	Lewis Lung Carcinoma 01/2019
1	Lymphatic Metastasis 01/2019
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 05/2017
1	Lung Neoplasms (Lung Cancer) 05/2017
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 05/2017

Drug/Important Bio-Agent (IBA)

6	Phenobarbital (Luminal)FDA Link 11/2021 - 06/2016
5	Biomarkers (Surrogate Marker)IBA 11/2022 - 12/2017
2	AntibodiesIBA 01/2024 - 02/2022
2	PanobinostatIBA 01/2023 - 02/2021
2	Estrogen ReceptorsIBA 11/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 11/2021 - 01/2020
2	Monoclonal AntibodiesIBA 04/2021 - 05/2020
2	Proteins (Proteins, Gene)FDA Link 04/2021 - 08/2013
2	CTLA-4 AntigenIBA 05/2020 - 01/2020
2	Tumor Biomarkers (Tumor Markers)IBA 01/2019 - 08/2013
2	LigandsIBA 07/2018 - 12/2017
1	CarbohydratesIBA 07/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	MucinsIBA 01/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023
1	Liposomes (Liposome)IBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 11/2022
1	Antineoplastic Agents (Antineoplastics)IBA 02/2022
1	2- amino- 3- (4'- N,N- bis(2- chloroethyl)amino)phenylpropionic acid N-oxideIBA 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2021
1	Estrogen Receptor alphaIBA 05/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2021
1	Keratins (Keratin)IBA 05/2021
1	Sirolimus (Rapamycin)FDA Link 03/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2021
1	neratinibIBA 03/2021
1	Tyrosine Kinase InhibitorsIBA 03/2021
1	Lapatinib (GW572016)FDA Link 03/2021
1	Colchicine FDA LinkGeneric 02/2021
1	tacedinaline (CI 994)IBA 02/2021
1	scriptaidIBA 02/2021
1	trichostatin A (A 300)IBA 02/2021
1	Vinblastine (Vinblastine Sulfate)FDA Link 02/2021
1	NocodazoleIBA 02/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2021
1	Histone Deacetylase InhibitorsIBA 02/2021
1	LeptinIBA 01/2021
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Leptin ReceptorsIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2020
1	CytokinesIBA 01/2019
1	Meglumine AntimoniateIBA 01/2019
1	miltefosine (Impavido)IBA 01/2019
1	CXCR4 Receptors (CXCR4 Receptor)IBA 07/2018
1	CXC ChemokinesIBA 12/2017
1	GlucocorticoidsIBA 05/2017
1	ErbB Receptors (EGF Receptor)IBA 08/2013

Therapy/Procedure

8	Therapeutics 01/2023 - 12/2017
4	Immunotherapy 11/2021 - 08/2013
2	Kidney Transplantation 10/2023 - 01/2023
2	Transplantation 01/2023 - 01/2019
1	Punctures 01/2024
1	Catheters 10/2023
1	Nephrectomy 10/2023
1	Precision Medicine 11/2022
1	Lymph Node Excision (Lymph Node Dissection) 08/2022
1	Nephroureterectomy 01/2022
1	Drug Therapy (Chemotherapy) 05/2017